Published in Cancer Res on September 15, 2000
Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol (2010) 2.48
DNA damage response in adult stem cells: pathways and consequences. Nat Rev Mol Cell Biol (2011) 1.57
Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53. Nat Genet (2009) 1.51
Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21. Mol Cancer Res (2011) 1.34
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer (2004) 1.16
Emerging strategies to boost thymic function. Curr Opin Pharmacol (2010) 1.12
Involvement of the Edar signaling in the control of hair follicle involution (catagen). Am J Pathol (2006) 1.01
p53/p63/p73 in the epidermis in health and disease. Cold Spring Harb Perspect Med (2014) 1.01
Removing all obstacles: a critical role for p53 in promoting tissue renewal. Cell Cycle (2010) 0.94
Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol (2007) 0.92
Intestinal stem cell injury and protection during cancer therapy. Transl Cancer Res (2013) 0.92
Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia. J Dermatol Sci (2010) 0.92
Bird's Nest View from a Dermatologist's Eye. Int J Trichology (2016) 0.92
Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes. Cell Cycle (2010) 0.89
Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models. Br J Cancer (2014) 0.88
Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist (2013) 0.88
Cellular Senescence as the Causal Nexus of Aging. Front Genet (2016) 0.80
Testing chemotherapeutic agents in the feather follicle identifies a selective blockade of cell proliferation and a key role for sonic hedgehog signaling in chemotherapy-induced tissue damage. J Invest Dermatol (2014) 0.79
Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress. PLoS One (2013) 0.79
Role for the epidermal growth factor receptor in chemotherapy-induced alopecia. PLoS One (2013) 0.78
The α-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: a pilot study. Surg Today (2011) 0.77
Complex changes in the apoptotic and cell differentiation programs during initiation of the hair follicle response to chemotherapy. J Invest Dermatol (2014) 0.77
Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage. J Cell Commun Signal (2015) 0.76
Hominis Placenta facilitates hair re-growth by upregulating cellular proliferation and expression of fibroblast growth factor-7. BMC Complement Altern Med (2016) 0.75
Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner. Oncogenesis (2017) 0.75
Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model. J Ginseng Res (2015) 0.75
A study on the extracts of Cuscuta reflexa Roxb. in treatment of cyclophosphamide induced alopecia. Daru (2014) 0.75
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99
A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92
The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (1998) 2.86
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A (1996) 2.66
Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser. N Engl J Med (1989) 2.30
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Home versus hospital deliveries: follow up study of matched pairs for procedures and outcome. Zurich Study Team. BMJ (1996) 2.10
Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06
Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J (1997) 1.96
Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene (2001) 1.95
Photoageing: mechanism, prevention and therapy. Br J Dermatol (2007) 1.94
Mast cells as sentinels of innate immunity. Curr Opin Immunol (1999) 1.85
Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84
Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78
Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol (1989) 1.71
Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest (1997) 1.66
EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy (2009) 1.65
Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology (2006) 1.65
Photoaging/photodamage and photoprotection. J Am Acad Dermatol (1990) 1.63
E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci (1994) 1.59
c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene (2007) 1.59
Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. Gene (2000) 1.57
How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J (2001) 1.54
Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52
Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol (1995) 1.52
Effect of aging and habitual sun exposure on the genetic response of cultured human keratinocytes to solar-simulated irradiation. J Invest Dermatol (1992) 1.52
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A (1996) 1.48
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A (2001) 1.43
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
Fatal recurrent subarachnoid hemorrhage after complete endovascular aneurysm occlusion. AJNR Am J Neuroradiol (2006) 1.40
Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene (1998) 1.40
The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy (2009) 1.39
Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J Virol (2001) 1.39
Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci (2009) 1.38
The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38
Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A (2008) 1.36
Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene (2001) 1.36
Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene (2000) 1.35
Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35
Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer (1976) 1.33
Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A (1997) 1.33
NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. Biochemistry (1999) 1.33
Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev (1998) 1.31
Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J Biol Chem (2000) 1.31
Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J (2000) 1.30
Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol (1987) 1.28
EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28
Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol (1994) 1.27
Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res (1993) 1.27
A simultaneous (15)N, (1)H- and (13)C, (1)H-HSQC with sensitivity enhancement and a heteronuclear gradient echo. J Biomol NMR (1995) 1.25
DNA damage and melanogenesis. Nature (1994) 1.25
Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol (1998) 1.25
Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol (2006) 1.24
9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways. Oncogene (2009) 1.24
p53 modulation of anchorage independent growth and experimental metastasis. Oncogene (1996) 1.23
Forward genetics in mammalian cells: functional approaches to gene discovery. Hum Mol Genet (1999) 1.22
Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21
The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol (1981) 1.20
Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene (2008) 1.20
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy (2014) 1.16
Re-engineering the toilet for sustainable waste water management. Environ Sci Technol (2001) 1.14
Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol (1984) 1.14
Rupatadine in allergic rhinitis and chronic urticaria. Allergy (2008) 1.13
Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol (2010) 1.12
Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem (1999) 1.12
Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol (1989) 1.12
Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. J Invest Dermatol (1983) 1.12
Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model. J Antibiot (Tokyo) (1982) 1.11
Growth of human keratinocytes on fibronectin -coated plates. Cell Biol Int Rep (1980) 1.10
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy (2013) 1.09
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2008) 1.08
Applications of green fluorescent protein as a marker of retroviral vectors. Somat Cell Mol Genet (1997) 1.08
The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy (2009) 1.07
Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res (1997) 1.06